Nirma had entered into a share purchase agreement dated September 21, 2023, with the Glenmark Pharmaceuticals and the target company Glenmark Life Sciences, whereby it agreed to acquire 9,18,95,379 shares, representing 74.84 per cent of the Voting Share Capital, subject to and in accordance with the terms and conditions contained in the SPA.
NSE to launch options contracts on WTI Crude Oil, Natural Gas in Top News on October 9: Glenmark Life Sciences board meet on Q2 results, dividend, share markets, Bank Nifty outlook, gold price today, New Zealand vs Netherlands ICC World Cup 2023 match also in focus in top stories today.